BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

  December 12, 2024

   · 

  2 min read
• Press Releases

  GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

  December 12, 2024

   · 

  3 min read
• Press Releases

  Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients

  December 12, 2024

   · 

  9 min read
• Press Releases

  Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer

  December 12, 2024

   · 

  8 min read
• Press Releases

  Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders

  December 12, 2024

   · 

  5 min read
• Press Releases

  PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy

  December 12, 2024

   · 

  4 min read
• Press Releases

  Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor

  December 12, 2024

   · 

  14 min read
• Press Releases

  BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

  December 12, 2024

   · 

  10 min read
• Press Releases

  Reunion Neuroscience Presented RE104 Phase 1 Data at the 2024 American College of Neuropsychopharmacology (ACNP) 63rd Annual Meeting

  December 12, 2024

   · 

  1 min read
• Press Releases

  Prospective Clinical Utility Study of Lucid Diagnostics’ EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

  December 12, 2024

   · 

  5 min read